Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.49 |
| ▸ | HTR1A | P08908 | 1/20 | 0.49 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.49 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.49 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.49 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.49 |
| ▸ | DRD1 | P21728 | 1/20 | 0.49 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.49 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.49 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.49 |
| ▸ | DRD3 | P35462 | 1/20 | 0.49 |
| ▸ | CASR | P41180 | 1/20 | 0.49 |
| ▸ | HTR2B | P41595 | 1/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30147199 | 0.92 | CYP3A4 (0.56) | CYP3A4LMNACHRM2HTR1AADRA2A | |
| SCHEMBL10231054 | 0.83 | CYP3A4 (0.53) | CYP3A4LMNACHRM2HTR1AADRA2A | |
| SCHEMBL14099965 | 0.83 | CYP3A4 (0.53) | CYP3A4LMNACHRM2HTR1AADRA2A | |
| SCHEMBL10231050 | 0.83 | CYP3A4 (0.53) | CYP3A4LMNACHRM2HTR1AADRA2A | |
| SCHEMBL10388847 | 0.73 | MTOR (0.38) | CYP3A4LMNACYP2D6CYP2C19KMT2A | |
| SCHEMBL10779809 | 0.73 | CYP3A4 (0.70) | CYP3A4LMNACHRM2HTR1AADRA2A | |
| SCHEMBL24406703 | 0.73 | CYP3A4 (0.76) | CYP3A4LMNACHRM2HTR1AADRA2A | |
| SCHEMBL3881700 | 0.73 | CYP3A4 (0.76) | CYP3A4LMNACHRM2HTR1AADRA2A | |
| SCHEMBL5471668 | 0.73 | CYP3A4 (0.76) | CYP3A4LMNACHRM2HTR1AADRA2A | |
| SCHEMBL3881699 | 0.73 | CYP3A4 (0.76) | CYP3A4LMNACHRM2HTR1AADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160206579-A1 | TAURINE OR TAURINE-LIKE SUBSTANCES FOR THE PREVENTION AND TREATMENT OF A DISEASE ASSOCIATED WITH RETINAL GANGLION CELL DEGENERATION | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2016-07-21 | — | — | US | claimed |
| US-20160193166-A1 | ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2016-07-07 | — | — | US | claimed |
| EP-2393490-A1 | TAURINE OR TAURINE-LIKE SUBSTANCES FOR THE PREVENTION AND TREATMENT OF A DISEASE ASSOCIATED WITH RETINAL GANGLION CELL DEGENERATION | INSERM - Institut National de la Santé et de la Recherche Médicale (FR) | 2011-12-14 | — | — | EP | claimed |
| US-20110172171-A1 | TAURINE OR TAURINE-LIKE SUBSTANCES FOR THE PREVENTION OF BRAIN OEDEMA | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2011-07-14 | — | — | US | claimed |
| EP-2326321-A1 | TAURINE OR TAURINE-LIKE SUBSTANCES FOR THE PREVENTION OF BRAIN OEDEMA | Inserm (Institut National de la Santé et de la Recherche Scientifique) (FR) | 2011-06-01 | — | — | EP | claimed |
| WO-2010089355-A1 | TAURINE OR TAURINE-LIKE SUBSTANCES FOR THE PREVENTION AND TREATMENT OF A DISEASE ASSOCIATED WITH RETINAL GANGLION CELL DEGENERATION | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2010-08-12 | — | — | WO | claimed |
| US-20100184707-A1 | ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2010-07-22 | — | — | US | claimed |
| EP-2167068-A2 | ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS | Inserm-Institut National De La Sante Et De La Recherche Medicale (FR) | 2010-03-31 | — | — | EP | claimed |
| WO-2010029021-A1 | TAURINE OR TAURINE-LIKE SUBSTANCES FOR THE PREVENTION OF BRAIN OEDEMA | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2010-03-18 | — | — | WO | claimed |
| EP-2163246-A1 | Taurine or taurine-like substances for the prevention of the irreversible visual effects of vigabatrin | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2010-03-17 | — | — | EP | claimed |
| WO-2009004082-A2 | ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2009-01-08 | — | — | WO | claimed |
| EP-2011491-A1 | Anticonvulsive pharmaceutical compositions | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2009-01-07 | — | — | EP | claimed |
| US-11998602-B2 | Methods for promoting myelination and for treating demyelinating diseases | THE SCRIPPS RESEARCH INSTITUTE (US) | 2024-06-04 | — | — | US | disclosed |
| US-20230022659-A1 | COMPOSITIONS AND METHODS FOR PRESERVING OR INCREASING PLATELET FUNCTION | WASHINGTON UNIVERSITY | 2023-01-26 | — | — | US | disclosed |
| US-20210023218-A1 | METHODS FOR PROMOTING MYELINATION AND FOR TREATING DEMYELINATING DISEASES | THE SCRIPPS RESEARCH INSTITUTE | 2021-01-28 | — | — | US | disclosed |
| WO-2019172969-A1 | METHODS FOR PROMOTING MYELINATION AND FOR TREATING DEMYELINATING DISEASES | THE SCRIPPS RESEARCH INSTITUTE (US) | 2019-09-12 | — | — | WO | disclosed |
| WO-2010029021-A1 | TAURINE OR TAURINE-LIKE SUBSTANCES FOR THE PREVENTION OF BRAIN OEDEMA | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2010-03-18 | — | — | WO | disclosed |
| EP-2163246-A1 | Taurine or taurine-like substances for the prevention of the irreversible visual effects of vigabatrin | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2010-03-17 | — | — | EP | disclosed |
| WO-2009004082-A2 | ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2009-01-08 | — | — | WO | disclosed |
| EP-2011491-A1 | Anticonvulsive pharmaceutical compositions | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2009-01-07 | — | — | EP | disclosed |